The latest closing stock price for Cue Biopharma as of November 20, 2024 is 1.09.
An investor who bought $1,000 worth of Cue Biopharma stock at the IPO in 2018 would have $-906 today, roughly -1 times their original investment - a -28.69% compound annual growth rate over 7 years.
The all-time high Cue Biopharma stock closing price was 30.73 on June 02, 2020.
The Cue Biopharma 52-week high stock price is 3.25, which is 198.2% above the current share price.
The Cue Biopharma 52-week low stock price is 0.45, which is 58.7% below the current share price.
The average Cue Biopharma stock price for the last 52 weeks is 1.65.
An investor who bought $1,000 worth of Cue Biopharma stock at the IPO in 2018 would have $-906 today, roughly -1 times their original investment - a -28.69% compound annual growth rate over 7 years.
The all-time high Cue Biopharma stock closing price was 30.73 on June 02, 2020.
The Cue Biopharma 52-week high stock price is 3.25, which is 198.2% above the current share price.
The Cue Biopharma 52-week low stock price is 0.45, which is 58.7% below the current share price.
The average Cue Biopharma stock price for the last 52 weeks is 1.65.